Back to Top

"One of today's leaders in investor relations and shareholder services"

Tag Archives: Marijuana

Terra Tech Corp. Expands Cannabis Cultivation Capabilities in Northern California with New “Craft Cultivation” Model

Company Signs New Craft Cultivator to Grow All-natural, Sustainably Produced Cannabis

IRVINE, CA–(Marketwired – May 24, 2017) – Terra Tech Corp. (OTCQX: TRTC) (“Terra Tech” or the “Company”), a vertically integrated cannabis-focused agriculture company, today announced that it has launched a new “Craft Cultivation” model to expand its cultivation capabilities, signing its first “Craft Cultivator” in Northern California. This farm, which is approved for up to one full acre (approximately 44,000 square feet) of cannabis cultivation and uses 22,000 square feet of engineered greenhouse space, is estimated to yield approximately one metric ton of the Company’s proprietary high grade “IVXX” cannabis on an annual basis.

Terra Tech has executed a one-year lease and operating contract with Panther Gap Farms, with the option to renew both the one-year lease and the operating contract a further three times in the following years. The property is located in Honeydew, CA, in Southern Humboldt …

Continue Reading

Posted in Client News| Tagged , , , , |
Kannaway LLC (MJNA)

A Closer Look at Kannaway LLC

Kannaway LLC (MJNA)

We’re always in search of other leaders in the cannabis industry who support and provide products to those who utilize the healing powers of medicinal marijuana and other similar products. Kannaway LLC is a subsidiary of Medical Marijuana, Inc. (MJNA). Kannaway reigns as the first lifestyle network to provide hemp-based botanical products to consumers. Their innovated products supply consumers with access to herbal blends and oils that support health and wellness through natural means.

Who Kannaway Is

Kannaway continuously strives to provide individuals with holistically sound choices for supplements and skincare products. They’re the first direct marketing company of its kind to give consumers access to legal hemp products. In 2014, the Academy of Multi-level Marketing awarded them with the title of “Start-up of the Year,” which was attributed to their rapid growth and solid foundation. Today, they’re continuing to guide the path of the cannabis market in the …

Continue Reading

Posted in Articles| Tagged , , , , |
AXIM

Medical Cannabis-Based Gum Moves into Production for Clinical Trials

AXIM

As of May 2, 2017, one of the world leaders in cannabinoid research and development declared their product development partner, Quay Pharmaceuticals Ltd., also known as Quay Pharma, acquired a license from the British Home Office to continue research related to AXIM’s MedChew Rx® line of pharmaceutical chewing gum. This particular license allows the British-based pharmaceutical company to work with controlled drugs in order to continue with the development process of the product.

Currently, MedChew RX® is made with 5 mg of cannabidiol (CBD) as well as an equivalent dosage of tetrahydrocannabinol (THC). When the drug does hit the market, it’ll be used to treat pain and spasms in patients who have multiple sclerosis (MS). This particular condition is a degenerative disease that affects the central nervous system and disrupts how the brain and body communicate with one another. Current research published by the National Organization for the Reform …

Continue Reading

Posted in Articles| Tagged , , , |

Medical Marijuana, Inc. Major Investment AXIM Biotech Moves Forward With Development Of MedChew Rx Pharmaceutical Chewing Gum

SAN DIEGO, May 3, 2017 /PRNewswire/ — Medical Marijuana, Inc. (OTC: MJNA), the first-ever publicly traded cannabis company in the United States, announced today that its major investment company AXIM® Biotechnologies, Inc.’s (AXIM® Biotech) (OTC: AXIM) product development partner Quay Pharmaceuticals Ltd. (“Quay Pharma”) has obtained the relevant licenses from the British Home Office to import and work with the controlled drugs that are required to continue the development of AXIM MedChew Rx® pharmaceutical chewing gum products.

MedChew Rx® is being developed as a pharmaceutical drug to treat pain and spasticity associated with multiple sclerosis (MS). It is formulated with 5 mg of cannabidiol (CBD) and 5 mg of tetrahydrocannabinol (THC).

The value of the MS treatment market is estimated to reach $20 billion by 2024, according to research firm GlobalData. This growth is primarily driven by the continued development of new products and an increase in diagnosis rates across …

Continue Reading

Posted in Client News| Tagged , , , |
Medical Marijuana (MJNA)

MJNA Financial Numbers Tell Story of a Company on the Rise

Medical Marijuana (MJNA)

Medical Marijuana, Inc., traded publicly under the ticker symbol MJNA, has made history as the world’s first cannabis company to be publicly traded in the United States. 2016 was a big year for the company with record growth, international import permissions being granted by multiple government agencies, and promising clinical trial results from MJNA’s revolutionary product lines.

Financial Growth

In the last quarter of 2016, Medical Marijuana, Inc.’s revenue increased by 66 percent compared to the first quarter of 2016. The company also had a Net Comprehensive Income increase of 731 percent compared to the same figure in 2015. Finishing out 2016 with a net income of greater than $8 million, the company is poised to break even more financial records in 2017. At least part of MJNA’s landmark success can be attributed to its portfolio of subsidiaries and investments, including new IP filings, international licensing and promising findings …

Continue Reading

Posted in Articles| Tagged , , , , |
Medical Marijuana, Inc. (MJNA)

MJNA in Washington on Capitol Hill Side by Side with Americans for Safe Access

Medical Marijuana, Inc.  (MJNA)

Obviously, when you purchase marijuana on the street, you’re not always sure what you’re getting. With different potencies and strains and even the fact that people lace weed with other drugs on occasion, buying marijuana from a dealer is a gamble. Not to mention, purchasing it on the streets is illegal. However, now that medical marijuana is becoming more well known and accepted throughout the country, many are lobbying for safe access to medicinal marijuana to alleviate any issues associated with purchasing marijuana and the regulation of it.

Medical Marijuana, Inc. (OTC: MJNA) are among those who are fighting for the cause. They were the ones to pave the way in the United States as the first publicly traded cannabis company. From April 7th to the 11th, representatives from MJNA attended the 5th Annual National Medical Cannabis Unity Conference at Omni Shoreham Hotel in Washington, DC. Experts, including scientists, …

Continue Reading

Posted in Articles| Tagged , , , |